Heart and Vascular
Additional Resources
Recently Added |View All
How pharmacogenomics is changing medication decisions
Genetic variants can affect how patients respond to medications. Learn how WellSpan Health is integrating pharmacogenomics into cardiovascular, oncology and psychotropic care to support safer, more personalized prescribing.
Why antiplatelet medication fails some patients and how genetic testing helps
About one-third of patients can’t metabolize Plavix effectively. Learn how genetic testing — available at no cost through WellSpan Health’s Gene Health Project — can guide decisions on safer antiplatelet therapy.
Q&A: Treating mitral regurgitation before it advances
Many patients with mitral regurgitation aren’t referred for treatment until they’re in advanced heart failure. Learn how careful imaging and percutaneous repair can help patients avoid advancing to that point.
TAVR keeps improving outcomes for aortic stenosis
Transcatheter aortic valve replacement (TAVR) has been an alternative to open surgery for decades. But many don’t know about its stunning results in reducing complications. Learn more from one of the nation’s leading TAVR experts.
Pulsed field ablation: The new first-line AFib treatment
Ablation procedures can improve AFib if patients are treated early enough. Pulsed field ablation is a new technology that offers this benefit with less risk of serious complications. Learn how it’s transforming the AFib treatment landscape.
Tips to detect CVD earlier in women
Women with cardiovascular disease (CVD) tend to receive later diagnoses and less aggressive treatment than men. Learn the unique signs of CVD in women and when to refer.
